Ang Huang

2.1k total citations · 1 hit paper
38 papers, 1.6k citations indexed

About

Ang Huang is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Ang Huang has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 11 papers in Immunology and 11 papers in Hepatology. Recurrent topics in Ang Huang's work include Liver Disease Diagnosis and Treatment (18 papers), Alcohol Consumption and Health Effects (9 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Ang Huang is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Alcohol Consumption and Health Effects (9 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Ang Huang collaborates with scholars based in China, United States and Australia. Ang Huang's co-authors include Karl J. Staples, Daniel C. Douek, Rob Lambkin‐Williams, Xiao-Ning Xu, Andrew J. McMichael, Tao Dong, John Oxford, Tom Wilkinson, Molly Perkins and Ben Nicholas and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ang Huang

35 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

2012 766 citations Ang Huang et al. profile →

Peers

Ang Huang

EPIDE

IMMUN

HEPAT

Ji‐Yuan Zhang China

Kyoko Sakai Japan

Anja Langenkamp Switzerland

Jeroen N. Stoop Netherlands

Juandy Jo Indonesia

Federico Martini Italy

Yuxian Huang China

Takayuki Matsumura Japan

Lê Hữu Song Vietnam

Fiona J. Plunkett United Kingdom

Ji‐Yuan Zhang China

Ang Huang

1.2k ×1.3

EPIDE

1.5k ×1.8

IMMUN

277 ×1.1

232 ×1.0

823 ×3.6

HEPAT

Citations per year, relative to Ang Huang Ang Huang (= 1×) peers Ji‐Yuan Zhang

Countries citing papers authored by Ang Huang

Since Specialization

Citations

This map shows the geographic impact of Ang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ang Huang more than expected).

Fields of papers citing papers by Ang Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ang Huang. The network helps show where Ang Huang may publish in the future.

Co-authorship network of co-authors of Ang Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Ang Huang. A scholar is included among the top collaborators of Ang Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ang Huang. Ang Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Xian, Ang Huang, Zherui Liu, et al.. (2025). Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms. Journal of Gastroenterology and Hepatology. 40(4). 987–1003. 1 indexed citations

Mietzsch, Mario, Ang Huang, Nicholas Smith, et al.. (2025). Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts. Nature Communications. 16(1). 3731–3731. 5 indexed citations

Wang, Xianling, Simin Chen, Chengwei Li, et al.. (2025). Psoralidin induces pyroptosis in both tumor cells and macrophages as well as enhances nature killer cell cytotoxicity to suppress hepatocellular carcinoma. Molecular Immunology. 184. 22–31.

Zhang, Chan, Congcong Wang, Mengxue Chen, et al.. (2025). Development of red grapefruit jam fermented with Monascus purpureus: Effect of naringenin on Monascus purpureus growth and metabolism. Food Bioscience. 65. 106061–106061. 1 indexed citations

Wen, X. Y., Xianling Wang, Simin Chen, et al.. (2025). Hypericin impedes M2 macrophage polarization and protects against Hepatocellular carcinoma. Molecular Immunology. 181. 160–168. 1 indexed citations

Qiu, Yuping, Mingzuo Jiang, Ang Huang, et al.. (2025). Quercetagetin alleviates liver fibrosis in non-alcoholic fatty liver disease by promoting ferroptosis of hepatic stellate cells through GPX4 ubiquitination. Chinese Medicine. 20(1). 89–89.

Xiong, Yüting, Jianfei Wang, Yan Liu, et al.. (2024). Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury. PubMed. 3(2). 100095–100095. 2 indexed citations

Huang, Ang, Zhe Dai, Ying Sun, et al.. (2024). Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD. Frontiers in Pharmacology. 15. 1437479–1437479. 3 indexed citations

Chang, Binxia, Hui Tian, Ang Huang, et al.. (2024). Prevalence and prediction of hepatocellular carcinoma in alcohol-associated liver disease: a retrospective study of 136 571 patients with chronic liver diseases. SHILAP Revista de lepidopterología. 2(1). e100036–e100036. 5 indexed citations

10.

Li, Kexin, Aileen Wee, Jimin Liu, et al.. (2022). Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury. Frontiers in Pharmacology. 13. 934467–934467. 3 indexed citations

11.

Wang, Chunyan, Ping Li, Sujun Zheng, et al.. (2021). Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study. Hepatology. 75(6). 1373–1385. 17 indexed citations

12.

Wang, Lingling, Ang Huang, Jiabo Wang, & Zhengsheng Zou. (2021). Chronic Drug-Induced Liver Injury: Updates and Future Challenges. Frontiers in Pharmacology. 12. 627133–627133. 26 indexed citations

13.

Huang, Ang, et al.. (2020). Huagan tongluo Fang improves liver fibrosis via down-regulating miR-184 and up-regulating FOXO1 to inhibit Th17 cell differentiation. Experimental and Molecular Pathology. 115. 104447–104447. 8 indexed citations

14.

Yan, Weiwei, Zhenyu Zhu, Fei Pan, Ang Huang, & Guanghai Dai. (2018). Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 1285–1292. 12 indexed citations

15.

Chang, Binxia, Ang Huang, Miaomiao Gao, et al.. (2018). Plasma levels of soluble ST2, but not IL‐33, correlate with the severity of alcoholic liver disease. Journal of Cellular and Molecular Medicine. 23(2). 887–897. 18 indexed citations

16.

Gao, Miaomiao, et al.. (2018). Granulocytic myeloid‐derived suppressor cell population increases with the severity of alcoholic liver disease. Journal of Cellular and Molecular Medicine. 23(3). 2032–2041. 18 indexed citations

17.

Chang, Binxia, Baosen Li, Ying Sun, et al.. (2017). Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013. Mediators of Inflammation. 2017. 1–5. 7 indexed citations

18.

Shang, Qinghua, Xinyue Chen, Weimin Nie, et al.. (2015). Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients. Cellular and Molecular Immunology. 12(3). 309–316. 85 indexed citations

19.

Huang, Ang, et al.. (2013). Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunology Immunotherapy. 62(9). 1439–1451. 180 indexed citations

20.

Zhang, Ji‐Yuan, Zhengsheng Zou, Ang Huang, et al.. (2011). Hyper-Activated Pro-Inflammatory CD16+ Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B. PLoS ONE. 6(3). e17484–e17484. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact